HIGHLIGHTS
- who: Sachie Nakagama et al. from the The study was approved by the Osaka Metropolitan UniversityVirginia Tech, United States have published the paper: Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response, in the Journal: (JOURNAL)
- what: This study showed that prior infection was predictive of enhanced and durable residual immunity against SARS-CoV-2 at 6 B Anti-spike antibody titers after BNT162b2 vaccination. The limitation of the study is the limited number of individuals evaluated. Despite these limitations, this study provides relevant information in a context where hybrid . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.